Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical.

Link to article at PubMed

Related Articles

Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical.

Clin Microbiol Infect. 2014 Dec 18;

Authors: Orasch C, Averbuch D, Mikulska M, Cordonnier C, Livermore DM, Gyssens IC, Klyasova G, Engelhard D, Kern W, Viscoli C, Akova M, Marchetti O, for the 4th European Conference on Infections in Leukemia (ECIL-4), a joint venture of Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (IDWP-EBMT), Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (IDG-EORTC), International Immunocompromised Host Society (ICHS), European Leukemia Net (ELN) and European Study Group on Infections in Immunocompromised Hosts of the European Society for Clinical Microbiology and Infectious Diseases (ESGICH-ESCMID)

PMID: 25658572 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *